G1 Therapeutics (GTHX)
(Delayed Data from NSDQ)
$7.09 USD
0.00 (0.00%)
Updated Aug 12, 2024 03:59 PM ET
After-Market: $7.08 -0.01 (-0.14%) 5:22 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.12 | 19.15% |
Earnings Summary
For their last quarter, G1 Therapeutics (GTHX) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.17 per share. This reflects a positive earnings surprise of 41.18%. Look out for GTHX's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year increase of 65.71%.
Earnings History
Price & Consensus
Zacks News for GTHX
Alector (ALEC) Reports Q2 Loss, Lags Revenue Estimates
GTHX: What are Zacks experts saying now?
Zacks Private Portfolio Services